Altos Labs

Congratulations to Morgan Levine on being named one of Business Insider's Rising Stars of Longevity. Morgan is leading the way on how to use artificial intelligence models to help unravel the biology of aging, and her well-deserved recognition reflects the impact of that work. We're proud to have her on our team!

We're pleased to be featured in The New York Times Magazine, which takes a close look at the science of cellular rejuvenation, and the researchers focused understanding it. Our team has made great progress unraveling this biology. Thanks to Susan Dominus for her time and allowing us to share more about our mission to use cellular rejuvenation to reverse disease, injury, and the disabilities that can occur throughout life. Read more: https://lnkd.in/eX_u644p

Congratulations to our president and co-founder Hans Bishop, who had the honor of being appointed by Cancer Research Horizons as a non-executive director to its board!

Congrats to Emily Leong Drayer for the well-deserved Healthcare Businesswomen’s Association Rising Star award. Emily’s impressive leadership experience, energy and one-team mindset are advancing our mission while making Altos Labs an amazing place to work. Kudos, Emily, and thanks for all you’re doing!

Altos Labs has been recognized on Forbes’ list of America’s Best Startup Employers for a second time among other top biotech startups and startups overall in the U.S. We’re thrilled to be on this list. It’s a testament to our talented and resilient colleagues and reflects the exceptional culture we’re building together rooted in a passion for scientific discovery and a commitment to fostering an inclusive, collaborative environment. Thanks to all our colleagues who helped us earn a spot on the list. We’re excited by what our team will achieve in the year ahead. https://lnkd.in/ernY8yFZ

We’re proud to share several recent achievements by our Institute of Computation (IoC) team, which leverages its expertise in artificial intelligence and computational biology to better understand the processes governing cell health and resilience. The Altos team won an exciting award at the Virtual Cell Challenge hosted by the Arc Institute for our custom generative perturbation-prediction model that achieved the most reliable performance and generalization across diverse evaluation criteria among 50 finalists. Our team developed its Cleo Flow Matching Model to infer heterogenous cellular responses to perturbations, an approach that enabled the team to capture fine-grained gene expression details, including complex gene-gene interactions. This recognition follows our team's participation at NeurIPS 2025, where we presented two papers regarding our tools: One, a collaborative effort with Microsoft Research, on scGeneScope, explores how retraining and testing state-of-the-art models to use our unique paired single‑cell RNA‑seq and Cell Painting image dataset can identify perturbations and mechanisms of action under realistic lab variability; a second paper discusses PerturBench, a standardized benchmarking platform for predicting cellular responses to genetic or chemical perturbations. Congratulations to the team! Learn more about the award here: https://lnkd.in/eBC8KMH5 Read the scGeneScope paper here: https://lnkd.in/e-ksDyXv Read the PerturBench paper here: https://lnkd.in/eNfxiZTk

Happy Halloween from our colleagues in the Bay Area, San Diego, and Cambridge who enjoyed celebrating this week – we’re grateful for every opportunity to bring our teams together!

Our team in San Diego gathered recently to celebrate our move to a new space! We’re excited for this new facility to deepen our incredible team’s collaboration as we pursue our mission to reverse disease, injury, and the disabilities that occur throughout life. We’re grateful to all the team members who made this move possible.

We are deeply saddened by the passing of Dr. David Baltimore, our Lead Independent Director. Dr. Baltimore’s leadership, scientific brilliance, and unwavering commitment to advancing the life sciences have left a lasting mark on both Altos and the scientific community at large. A Nobel laureate and pioneering molecular biologist, Dr. Baltimore’s influence as a generous mentor and trusted advisor will continue to span generations. His visionary guidance was key in shaping Altos’ mission and driving our team to pursue groundbreaking advances in science. We extend our heartfelt condolences to his family, friends, and all those inspired by his remarkable legacy.

We are pleased to announce that Dr. Joan Mannick has joined Altos as our new Senior Vice President, Chief Medical Officer, and Head of Product Development. In this role, Dr. Mannick will work within our Institute of Medicine to provide medical and scientific leadership focused on translating our research into transformative therapies as we advance our mission to reverse disease. Learn more about Dr. Mannick and her role at Altos: https://lnkd.in/egDuHTSk